Development and validation of LC/MS/MS method for the simultaneous determination of montelukast, gliclazide, and nifedipine and its application to a pharmacokinetic study

BACKGROUND: Montelukast is a leukotriene receptor antagonist for treatment of asthma, gliclazide is an oral hypoglycemic antidiabetic agent, and nifedipine is a calcium channel blocker used for treatment of angina pectoris and hypertension. These drugs may be prescribed to patients suffering from th...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Ezzeldin, Essam, Abo-Talib, Nisreen F, Tammam, Marwa H, Shahat, Abdelaaty A
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2014
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3984717/
https://ncbi.nlm.nih.gov/pubmed/24618480
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1752-153X-8-17
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak